Skip to main content

Intracranial Hypertension Induced by Rofecoxib

Buy Article:

$51.00 plus tax (Refund Policy)

Abstract:

Several secondary causes are implicated in the etiology of idiopathic intracranial hypertension. Rofecoxib is a selective cyclo-oxygenase (COX)-2 inhibitor, now being increasingly used in place of nonselective nonsteroidal anti-inflammatory drugs (NSAIDs). We report a case of intracranial hypertension in a 69-year-old man 3 weeks after the commencement of rofecoxib therapy with reversal of clinical findings on drug withdrawal.

(Headache 2005;45:75-88)

Keywords: intracranial hypertension; rofecoxib

Document Type: Research Article

DOI: https://doi.org/10.1111/j.1526-4610.2005.05013.x

Publication date: 2005-01-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more